State of the art of low-density lipoprotein apheresis in the year 2003

Therapeutic Apheresis and Dialysis

Volumn 8, Issue 2, 2004, Pages 76-79

  Bosch, Thomas ^a   Wendler, Thorsten ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Apheresis; Coronary events; Direct adsorption of lipids; Low density lipoprotein; Low density lipoprotein apheresis; Low density lipoprotein cholesterol; Review

Indexed keywords

ALBUMIN; ANTILIPEMIC AGENT; BLOOD CLOTTING FACTOR; HEPARIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; LOW DENSITY LIPOPROTEIN;

ANGINA PECTORIS; APHERESIS; ATHEROGENESIS; BLOOD FILTRATION; BLOOD RHEOLOGY; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; EXTRACORPOREAL CIRCULATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LOW DENSITY LIPOPROTEIN APHERESIS; MORTALITY; PERCEPTION DEAFNESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TREADMILL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADSORPTION; BLOOD COMPONENT REMOVAL; BLOOD FLOW VELOCITY; CELL ADHESION MOLECULES; CHOLESTEROL, LDL; CORONARY DISEASE; HEARING LOSS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MACULAR DEGENERATION; PLASMAPHERESIS; TIME FACTORS;

EID: 2942720463     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-0968.2003.00120.x     Document Type: Review

References (20)

1. Mabuchi H, Koizumi J, Shimizu M et al. for the Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 1998;82:1489-95.
2. Thompson GR. LDL apheresis. Atherosclerosis 2003;167:1-13.
3. Matsuzaki M, Hiramori K, Imaizumi T et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the low density lipoprotein-apheresis coronary morphology and reserve trial (LACMART). JACC 2002;40:220-7.
4. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36:1253-60.
5. Hoffmann U, Derfler K, Haas M, Stadler A, Brady TJ, Kostner K. Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography. Am J Cardiol 2003;91:461-4.
6. Schamberger BM, Geiss HC, Ritter MM, Schwandt P, Parhofer KG. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia. J Lipid Res 2000;41:727-33.
7. Empen K, Otto C, Brödl UC, Parhofer KG. The effects of three different LDL-apheresis methods on the plasma concentations of E-selectin, VCAM-1 and ICAM-1. J Clin Apheresis 2002;17:38-43.
8. Bosch T, Keller C. Clinical effects of direct adsorption of lipoprotein apheresis: Beyond cholesterol reduction. Ther Apher Dial 2003;7:341-4.
9. Wendler T, Schilling R, Lennertz A et al. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study. J Clin Apheresis 2003;18:157-66.
10. Suckfüll M et al. for the Hearing Loss Study Group. Fibrinogen and LDL-apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-7. Erratum in Lancet 2003;361:1916.
11. Suckfüll M et al. for the Hearing Loss Study Group. Fibrinogen and LDL-apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811-7. Erratum in Lancet 2003;361:1916.
12. Klingel R, Fassbender C, Fischer I et al. Rheopheresis for age-related macular degeneration: a novel indication for therapeutic apheresis in ophthalmology. Ther Apher 2002;6:271-81.
13. Susca M. Heparin-Induced extracorporeal low-density lipoprotein precipitation futura, a new modification of HELP apheresis: technique and first clinical results. Ther Apher 2001;5:387-93.
14. Bosch T, Lennertz A, Samtleben W. High-efficiency DALI apheresis using 1,250 ml adsorbers in a hypercholesterolemic obese patient: a case report. Ther Apher 2001;5:358-63.
15. Klingel R, Fassbender T, Fassbender C, Göhlen B. From membrane differential filtration to lipidfiltration: Technological progress in low-density lipoprotein apheresis. Ther Apher Dial 2003;7:350-8.
16. Mellwig KP, Baller D, Gleicmann U et al. Improvement of coronary vasodilation capacity through single LDL apheresis. Atherosclerosis 1998;139:173-8.
17. Bosch T, Wendler T, Jaeger BR, Samtleben W. Improvement of Hemorheology by DALI Apheresis: Acute Effects on Plasma Viscosity and Erythrocyte Aggregation in Hypercholesterolemic Patients. Ther Apher 2001;5:372-6.
18. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997;95:76-82.
19. Koga N, Watanabe K, Kurashige Y, Sato T, Hiroki T. Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients. J Intern Med 1999;246:35-43.
20. Otto C, Kern P, Bambauer R et al. Efficacy and Safety of a New Whole-blood Low-density Lipoprotein Apheresis System (Liposorber D) in Severe Hypercholesterolemia. Artif Organs 2003;27:1116-22.